Logo

Galileo Genomics Gets $CA7 Million Loan from Investissement Quebec

Jan 19, 2004

NEW YORK, Jan. 19 (GenomeWeb News) - Galileo Genomics has received a loan of $CA7 million ($5.39 million) from Investissement Quebec, the company said today.

 

Galileo, based in Montreal, plans to use the additional funding for its research. Applying its chromozoom technology, the company is trying to find groups of genes associated with more than 20 common diseases by examining DNA samples from the Quebec Founder Population.

 

Earlier this month, Galileo raised $CA11.15 million ($8.58 million) in equity financing.

 

Breaking News
The Scan

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.

Family Genetic Risk Score Linked to Diagnostic Trajectory in Psychiatric Disorders

Researchers in JAMA Psychiatry find ties between high or low family genetic risk scores and diagnostic stability or change in four major psychiatric disorders over time.

Study Questions Existence of Fetal Microbiome

A study appearing in Nature this week suggests that the reported fetal microbiome might be the result of sample contamination.

Fruit Fly Study Explores Gut Microbiome Effects on Circadian Rhythm

With gut microbiome and gene expression experiments, researchers in PNAS see signs that the microbiome contributes to circadian rhythm synchronicity and stability in fruit flies.